Ependymoma Drug Market to Surpass US$ 208.4 Mn, expected to exhibit a CAGR of 4.8% by 2030 | Fera Pharmaceuticals, Pfizer, Novartis AG, Merck KGaA, Baxter
Increased research project launches for ependymoma is one of the key industry trends that is anticipated to fuel the growth of the global ependymoma medication market over the forecast period. For instance, the Edie’s Butterfly Appeal-funded research effort to create a novel, non-invasive method to diagnose the various forms of ependymoma brain tumours was begun by the Children’s Cancer and Leukaemia Group in August 2020. In order to fund research into childhood ependymoma, a tumour that frequently develops in very young children’s brain or spinal cord, Edie’s Butterfly Appeal was established in 2014.
Get Research Sample PDF with Market Development Insights @ https://www.coherentmarketinsights.com/insight/request-sample/5332
Impact
Key industry stakeholders were affected by the COVID-19 pandemic’s significant disruptions to clinical trial execution in the United States. Companies that support drug development, such as sponsors and contract research companies (CROs), have transitioned to remote working arrangements. The U.S. Food and Drug Administration (FDA) recently stated that the impact of COVID-19 may necessitate organisations conducting clinical trials to explore virtual patient visits or establish new processes in place of existing protocols. As a result, there are additional possibilities for using remote healthcare, such as running virtual or decentralised studies, using site-less clinical trials, or using other unconventional strategies that do not require in-person visits.
Additionally, the presence of several social organisations that provide assistance to patients with brain tumours is anticipated to fuel market expansion throughout the course of the forecast period. A national, non-profit organisation like The Brain Tumour Foundation of Canada (BTFC) is one example. Its mission is to support, educate, and inform everyone in Canada afflicted by brain tumours.
Key Takeaways
A CAGR of 4.8% is anticipated for the global ependymoma medication market during the forecast period as a result of rising ependymoma treatment-related research & development activities. For instance, researchers from China demonstrated in November 2020 that radiation and anti-cancer poly [ADP-ribose] polymerase (PARP) inhibitors may be used to treat ependymoma tumours that express high levels of the protein chromosomal X open reading frame 67. (CXorf67).
Due to the rising prevalence of ependymoma, the hospital pharmacy segment is anticipated to have a dominating position in the worldwide ependymoma medicine market over the forecast period. Due to rising government funding for brain cancer medications, Asia Pacific is anticipated to experience the highest CAGR in the worldwide ependymoma drug market over the course of the forecast period. For instance, as part of its efforts to better the lives of those affected by the disease, the Australian government announced in October 2017 that it will invest $100 million in brain cancer research.
Baxter, Fera Pharmaceuticals, Merck KGaA, Pfizer, Moleculin Biotech, Inc. Novartis AG, APOTEX INC, Cipla Limited, UCB, Inc., Zydus Cadila, and Lupin Pharmaceuticals, Inc. are significant competitors in the global ependymoma medication market.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channels
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Regulatory Scenario
- Market Trends
- Key Developments
- Epidemiology
- PEST Analysis
- Collaboration and Acquisition
- Porters Analysis
- Pipeline Analysis
- Market Dynamics
- Global Ependymoma Drug Market– Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Demand and Supply
- COVID-19 Impact Assessments
- Global Ependymoma Drug Market, By Drug Type, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Antiseizure Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Others
- Introduction dna
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Introduction
- Global Ependymoma Drug Market, By Disease Type, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Subependymoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Myxopapillary Ependymoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Anaplastic Ependymoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Classic Ependymomas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Introduction
- Global Ependymoma Drug Market, By Distribution Channel, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/ependymoma-drug-market-4629
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Email: [email protected]
Phone: U.S.: +1-206-701-6702
U.K.: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837